Literature DB >> 14281368

THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.

A P FLETCHER, N ALKJAERSIG, S SHERRY, E GENTON, J HIRSH, F BACHMANN.   

Abstract

Entities:  

Keywords:  ANGIOGRAPHY; DRUG THERAPY; FIBRINOLYSIS; GERIATRICS; INFUSIONS, PARENTERAL; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS; THROMBOPLASTIN; THROMBOSIS

Mesh：

Substances：

Year:  1965        PMID： 14281368

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  17 in total

1.  Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors:  P Golino; J T Willerson
Journal:  Tex Heart Inst J       Date:  1991

Review 2.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Clinical experience with brinase.

Authors:  E P Frisch
Journal:  J Clin Pathol       Date:  1972-07       Impact factor: 3.411

4.  Defibrination syndrome in phlegmasia ceruleaolens.

Authors:  G L Saha
Journal:  Postgrad Med J       Date:  1969-01       Impact factor: 2.401

5.  Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans.

Authors:  B Nunn; A Esmail; R Fears; H Ferres; R Standring
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.

Authors:  C Korninger; O Matsuo; R Suy; J M Stassen; D Collen
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.

Authors:  Y Takeda; T R Parkhill; M Nakabayashi
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

Review 9.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 10.  Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors:  J Nazari; R Davison; K Kaplan; D Fintel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.